Mill Creek Life Sciences was founded in 2010 in Rochester, MN, a manufacturer of human platelet lysate supplements designed to accelerate regenerative medicine therapies. This technology was licensed from the Mayo Clinic, one of the world’s leading non-profit medical centers in the US. As the first to create human platelet lysate for the research market – PLTMax and PLTGold are leading global brands. Products include research-grade, clinical-grade, gamma-irradiated, and pathogen-inactivated formats.
Since 2017, members of the Captivate Bio team have worked to establish strategies for the adoption of human platelet lysate as a superior and acceptable supplement to fetal bovine serum in stem cell research and therapeutic applications. In 2020, Captivate Bio signed an contract extension to distribute PLTMax and PLTGold products to research and therapeutic markets worldwide.
Learn more about Mill Creek Life Sciences at millcreekls.com.
Planning your next research project has never been easier. Reserve your next order of Human Platelet Lysate with Captivate Bio and save 5% on your total order with a PO. With demand high, securing your supply is more critical than ever. Contact us today to get started.
This Research Spotlight highlights the use of gamma irradiated PLTMax and PLTGold, showing improved safety profile, cell yield, and cellular phenotype in comparison to other products available in the market.
New advancements in clinically safe and effective human platelet lysate T cell culture supplements advance CAR-T therapy applications.
This Research Spotlight highlights T cell expansion and the use of gamma irradiated human platelet lysate for use in bioprocessing and T cell and CAR-T manufacturing workflows.
